RecruitingNot ApplicableNCT07298317

Safety and Performance of the OTTAVA System in Participants Undergoing Inguinal Hernia Repair

Technology Evaluation in a Multi-Center Study of Safety and Performance of the OTTAVA System


Sponsor

Auris Health, Inc.

Enrollment

30 participants

Start Date

Mar 11, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to assess safety and performance of the OTTAVA System, through 30 days postoperative, in participants undergoing robotic-assisted inguinal hernia repair (IHR).


Eligibility

Min Age: 22 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called OTTAVA Robotic System for people with hernia, inguinal. The study is currently recruiting participants at 4 locations. People eligible for this study include aged 22 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEOTTAVA Robotic System

Participants will undergo the IHR procedure using OTTAVA Robotic System.


Locations(4)

Tampa General Hospital

Tampa, Florida, United States

Indiana University North Hospital

Carmel, Indiana, United States

Duke Regional Hospital

Durham, North Carolina, United States

The University of Texas Health Science Center at Houston

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07298317


Related Trials